Test Price
2,800 AED✅ Home Collection Available
CYCS Gene Thrombocytopenia Type 4 Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
99.9% Diagnostic Accuracy – ISO‑certified processing with Next Generation Sequencing (NGS). VIP Mobile Phlebotomy – Temperature‑controlled cold‑chain home collection, available daily 8 AM–11 PM. Complimentary Telephonic Post‑Test Consultation for clinical result interpretation. Insurance Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test uses Next Generation Sequencing (NGS) to comprehensively analyze the CYCS gene, identifying pathogenic variants responsible for congenital thrombocytopenia type 4 – a rare inherited bleeding disorder. The assay covers all coding exons, intron/exon boundaries, and detects copy number variations (CNVs), providing a definitive molecular diagnosis that guides lifelong clinical management for patients and their families.
| Feature | CYCS NGS Test | Sanger Sequencing (Alternative) |
|---|---|---|
| Methodology | NGS – full gene sequence (exons, intron boundaries, CNV detection) | Sanger sequencing of coding exons only |
| Diagnostic Sensitivity | 99.9% | ~95% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price (AED) | 2,800 AED | 2,500 AED |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that this genetic test provides a definitive molecular diagnosis for CYCS‑related thrombocytopenia, but it must be interpreted within the full context of the patient’s platelet count, bleeding history, and family pedigree. A positive result confirms the hereditary basis of the disorder and enables targeted surveillance and family screening. Clinical correlation remains essential.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Safety Advisory
Do not discontinue any prescribed medication (including antiplatelet or anticoagulant therapy) without the explicit guidance of your treating physician. Genetic results should complement, not replace, current clinical management.
Exclusion Criteria & Emergency Red Flags
- Active major bleeding (e.g., intracranial, gastrointestinal) – seek emergency care immediately.
- Recent platelet transfusion (within 4 weeks) may cause false‑negative results; reschedule testing.
- Acquired thrombocytopenia (ITP, DIC, drug‑induced) must be ruled out before genetic testing.
- If you experience sudden severe headache, widespread petechiae, melena, or uncontrolled epistaxis, call 998 or proceed to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the CYCS Gene Thrombocytopenia Type 4 Genetic Test?
This advanced genetic test uses Next Generation Sequencing to analyze the entire CYCS gene, identifying disease‑causing variants associated with congenital thrombocytopenia type 4. It provides a definitive molecular diagnosis for this rare inherited bleeding disorder, guiding both long‑term management and family cascade screening.
2. How is the sample collected and what preparation is needed?
A certified phlebotomist will visit your home to draw a small blood sample (3–5 mL) into a specialized DNA tube. The sample is transported in a temperature‑controlled cold chain to our ISO‑certified laboratory. No fasting is required, but a mandatory pre‑test genetic counseling session will document your three‑generation family pedigree prior to collection.
3. What do the results mean and how will I receive them?
Your report classifies each variant as pathogenic, likely pathogenic, or a variant of uncertain significance (VUS), accompanied by a clinical correlation note from a consultant medical geneticist. Results are delivered through our secure patient portal and explained during a scheduled telephonic consultation to ensure full understanding of the implications.
UAE Regulatory & Data Privacy Adherence
This service strictly complies with the following UAE legal frameworks:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal and genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health data management.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – safeguarding patient safety and informed consent in clinical testing.
All genetic analyses are performed within our ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139). Your privacy is our priority.
Clinical & Logistical Metadata
| Test Name | CYCS Gene Thrombocytopenia Type 4 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene coverage including all exons, intron/exon boundaries, and CNV detection |
| ICD‑10‑CM Code | D69.4 (Congenital Thrombocytopenia) |
| LOINC Code | 81499‑9 (Cytochrome c gene sequencing in Blood) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Operated by DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians